Navigation Links
Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
Date:6/8/2009

d sustain glycemic control.(vi,vii)

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar levels. BYETTA is an add-on therapy for people currently using metformin, a sulfonylurea, or a thiazolidinedione. BYETTA provides sustained A1C control and low incidence of hypoglycemia when used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. BYETTA was approved in April 2005 and has been used by more than one million patients since its introduction. For full prescribing information, visit www.BYETTA.com.

Important Safety Information for BYETTA

BYETTA improves glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione. BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney.

When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To reduce this possibility, the dose of sulfonylurea medicine may need to be reduced while using BYETTA. Other common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery and acid stomach. Nausea is the most common side effect when first starting BYETTA, but decreases over tim
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
7. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
8. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 Konica ... achieved record sales growth for fiscal year ended ... digital radiography family of Primary Imaging Solutions.  The ... fueled company growth to double digit sales figures ... solutions includes the AeroDR XE, a wireless flat ...
(Date:4/28/2015)... 28, 2015  nUro, Inc. (the "Company") announced ... invest in Rosellini Scientific Benelux, SPRL. This marks the ... equity injections and one acquisition). nUro, Inc. plans to ... rapid prototyping labs in Wallonia and in conjunction ... investment comes in conjunction with notice of an ...
(Date:4/28/2015)... BIRMINGHAM, Ala. , April 28, 2015 /PRNewswire/ ... solution company for quickly and accurately capturing complete ... introduces the rebranding of its software platform to ... learns and simplifies what surgeons need to successfully ... unreasonable and unacceptable burden on surgeons to micro-dictate ...
Breaking Medicine Technology:Konica Minolta Sets Record Digital Radiography Sales 2nUro, Inc. Invests in Wallonia-Based Medtech Company 2nUro, Inc. Invests in Wallonia-Based Medtech Company 3nUro, Inc. Invests in Wallonia-Based Medtech Company 4Vincari introduces Lightspeed Valet, a web and mobile software solution for delivering ICD-10 surgical documentation at the point-of-care with extreme speed and accuracy 2
... 3, 2011 Clinicians may soon have a new tool ... – one of the most common sexually transmitted infections in ... and Company) (NYSE: BDX ), announced today that ... clearance for the first fully automated molecular tests to diagnose ...
... 2011 See video from Endo Pharmaceuticals at: ... The FDA has approved Fortesta™ (testosterone) ... low testosterone or "Low T," a condition that ... States. Available content includes an audio news release, ...
Cached Medicine Technology:New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients 2
(Date:4/28/2015)... April 28, 2015 Aultman Hospital ... Advantage (WCA) to transition its outpatient wound center ... hospital’s commitment to the specialty of wound care ... the country currently working with Wound Care ... advanced wound care treatments and hyperbaric oxygen therapy ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Consolidated ... are moving forward nationwide, as courts overseeing proceedings ... next month. According to court documents issued in ... the next status conference in the federal Xarelto ... 9:00 a.m. C.S.T. (In Re: Xarelto Products ...
(Date:4/28/2015)... Orange, N.J. (PRWEB) April 28, 2015 Seton ... of Kathleen M. Boozang as the new Dean of Seton ... Dean effective July 1, 2015. , Boozang, currently Associate ... Hall Law in 1990. She helped launch and currently ... Law & Policy, ranked a Top 10 law health ...
(Date:4/28/2015)... April 28, 2015 April 8th, ... Debbie Durkin’s “RockNRolla Movie Awards” EcoLuxe Lounge, with ... event. Durkin Entertainment, Los Angeles’ leading producer of ... the organizing force behind this event, which featured ... and socially conscious products and services. The EcoLuxe ...
(Date:4/28/2015)... April 28, 2015 Children’s Medical ... the cause of medical foods and formulas through ... as the organization’s new executive director. , Thousands ... health consequences because of conditions and diseases that ... diet. To live and thrive, they are ...
Breaking Medicine News(10 mins):Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 2Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 3Health News:Choices Recovery South Bend Examines Support Systems in Treatment with Hollywood's Mike Pericoloso 2Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2
... experience their dark moods in an on-again, off-again,fashion. In ... the oscillations follow a seasonal schedule, with the depression,usually ... Lack of light,is often blamed for SAD, but just ... in question, reports the January 2008 issue of the,Harvard ...
... Marks a New Era for Casino Patrons and Employees, ... Jan. 1, 2008, employees,and visitors at Colorado casinos will ... will be completely smoke-free to comply with the,Colorado Clean ... will,protect casino employees and guests from exposure to secondhand ...
... Noncombat-related acute and recurrent chronic pain are the leading causes ... as low as 2 percent when these soldiers are treated ... 95 percent when troops and officers are treated and managed ... elsewhere for therapy, according to a new study from a ...
... without diet changes, study finds , , MONDAY, Dec. 17 (HealthDay ... week is enough to undo metabolic syndrome, a health condition ... new study suggests. , "What we found was a modest ... metabolic syndrome risk," said study author Johanna L. Johnson, a ...
... John P. Murtha, Chairman of the House Appropriations Subcommittee on ... behalf of veterans blinded by war and for research to ... the Institute gives the Man of Vision Award to an ... the awareness of the challenges of vision loss. Among previous ...
... effort to help,prepare today,s students to become ... Nations Environment Programme,s North American,Regional Office (UNEP ... Day,partnership and launched the International Children,s Painting ... Children,s Painting Competition (ICPC) invites,elementary and middle ...
Cached Medicine News:Health News:Lack of Light and Seasonal Depression - What's the Link? From the Harvard Health Letter 2Health News:Colorado Casinos Clear the Air and Become Smoke-Free in 2008 2Health News:Colorado Casinos Clear the Air and Become Smoke-Free in 2008 3Health News:Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength 2Health News:Moderate Exercise Cuts Risk of Metabolic Syndrome 2Health News:Moderate Exercise Cuts Risk of Metabolic Syndrome 3Health News:Champion of blinded soldiers, Congressman Murtha, is Man of Vision 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 3Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 4
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Colorimetric Assay of Antiplasmin Activity by STA© Analyzers...
HbA1c / HbCalibrator...
Medicine Products: